Estimated HIV Incidence and Prevalence in the United States 2010–2016
This report discusses the estimated HIV incidence and prevalence in the United States 2010–2016.
This report discusses the estimated HIV incidence and prevalence in the United States 2010–2016.
This webpage discusses the significant decline in cervical precancers (CIN2+) observed between 2008 and 2022, particularly in women aged 20–24, correlating with HPV vaccination.
This journal presents a spatial–temporal modeling study examining how city-level sociodemographic and health-related factors influenced the prevalence of antimicrobial-resistant gonorrhea in the U.S. from 2000 to 2019.
This report provides an early analysis of cases of tuberculosis (TB) disease reported to the Centers for Disease Control and Prevention (CDC) during 2024 as compared with previous years. CDC used U.S. Census Bureau population estimates to calculate rates (cases per 100,000 persons) of TB disease.
This webpage presents data on newly reported chronic hepatitis C cases in Alaska from 2016 to 2023. It underscores the importance of continued hepatitis C surveillance to guide targeted testing and treatment efforts toward disease elimination.
This report outlines progress toward eliminating mother-to-child transmission of hepatitis B virus (HBV) in the Americas from 2012 to 2022. It highlights improvements in vaccination coverage, including birth doses, but also notes coverage declines in some countries, which could hinder elimination goals. The report emphasizes the need for maintaining high vaccination rates, expanding hepatitis B testing for pregnant women, and ensuring timely treatment for newborns.
This video explains HIV self-testing, a private and convenient way to check one’s HIV status in as little as 20 minutes. It highlights how to interpret test results and explores available prevention and treatment options to support early detection and care.
This journal explores the evolution of HIV diagnostic testing, from early antibody-based methods to advanced molecular and rapid point-of-care technologies. It highlights the impact of these innovations on early detection, treatment initiation, and global efforts to control HIV transmission.
This fact sheet discusses the clinical summary of the USPSTF Recommendation for serologic screening for genital herpes infection.